Showing results (511-520 of 1,644) with videos related to
Sort By:
Pageof 165
Expert Opinion on Drug Safety|November 13, 2015
Tazarotene foam, 0.1%, for the treatment of acneJaclyn A Smith, Swetha Narahari, Dane Hill, et al.Clinical and Experimental Dermatology|February 10, 2023
Characterizing the burden of calciphylaxis: a qualitative analysisRohan Singh, Sarah McCain, Steven R Feldman, et al.Antibiotics (Basel, Switzerland)|February 27, 2026
Outpatient Cutaneous Wound Care in the United States: Specialty Distribution and Antimicrobial Prescribing PatternsAyman Grada, Rithi John Chandy, Jiwon Park, et al.Expert Opinion on Pharmacotherapy|April 20, 2019
Evaluating crisaborole as a treatment option for atopic dermatitisVignesh Ramachandran, Abigail Cline, Steven R Feldman, et al.Journal of Cutaneous Medicine and Surgery|June 20, 2015
Tolerability of Topical Retinoids: Are There Clinically Meaningful Differences Among Topical Retinoids?Leonora Culp, Sara Moradi Tuchayi, Hossein Alinia, et al.Cutis|May 19, 2006
Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United StatesRajesh Balkrishnan, Amit S Kulkarni, Kimberly Cayce, et al.Plos Medicine|November 24, 2006
What is the best approach to reducing birth defects associated with isotretinoin?Lorien Abroms, Edward Maibach, Katherine Lyon-Daniel, et al.The Journal of Dermatological Treatment|May 25, 2018
Biologics monitoring: incongruity between recommendations and clinician monitoring trendsAnish Nadkarni, Kimberly Hyde, Leah A Cardwell, et al.Hospital & Health Services Administration|June 9, 1984
Employer perspectives on the preferred provider organization conceptJ E Kralewski, R Feldman, B E Dowd, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|November 14, 1998
Adherence to pharmacologic management of hypertensionR Feldman, M Bacher, N Campbell, et al.Pageof 165